Aqumeldi Euroopa Liit - leedu - EMA (European Medicines Agency)

aqumeldi

proveca pharma limited - enalapril (maleate) - Širdies nepakankamumas - renino ir angiotenzino sistemos veikiantys vaistai - treatment of heart failure.

Spironolactone Ceva Euroopa Liit - leedu - EMA (European Medicines Agency)

spironolactone ceva

ceva santé animale - spironolaktonas - diuretikai - Šunys - vartoti kartu su standartine terapija (įskaitant, jei reikia, diuretikų palaikymą) širdies vožtuvo regurgitacijos sukeltam širdies nepakankamumui gydyti.

Zeleris Euroopa Liit - leedu - EMA (European Medicines Agency)

zeleris

ceva santé animale - florfenikolio, meloksikamas - amphenicols, deriniai, antibacterials sisteminio naudojimo - galvijai - už terapinis gydymas, galvijų kvėpavimo takų ligų (brd), susijusių su pyrexia dėl mannheimia haemolytica, pasteurella multocida ir histophilus somni jautrūs florfenikolio.

GRIVIX Leedu - leedu - SMCA (Valstybinė vaistų kontrolės tarnyba)

grivix

zakłady farmaceutyczne polpharma s.a. - dimetindeno maleatas - gelis - 1 mg/g; 1 g - dimetindene

Sycrest Euroopa Liit - leedu - EMA (European Medicines Agency)

sycrest

n.v. organon - asenapine (as maleate)  - bipolinis sutrikimas - psicholeptikai - sycrest skiriamas vidutinio sunkumo ar sunkių manijos epizodų, susijusių su bipoliniu i sutrikimu, gydymui suaugusiems.

Doptelet Euroopa Liit - leedu - EMA (European Medicines Agency)

doptelet

swedish orphan biovitrum ab (publ) - avatrombopag maleate - trombocitopenija - antihemoraginiai - doptelet fluorouracilu gydyti sunkia trombocitopenija suaugusiųjų pacientams, sergantiems lėtine kepenų liga, kas yra planuojama atlikti invazinės procedūros. doptelet is indicated for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e. kortikosteroidai, imunoglobulinai).

Daurismo Euroopa Liit - leedu - EMA (European Medicines Agency)

daurismo

pfizer europe ma eeig - glasdegib maleate - leukemija, mieloidas, ūmus - antinavikiniai vaistai - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.

Jyseleca Euroopa Liit - leedu - EMA (European Medicines Agency)

jyseleca

gilead sciences ireland uc, galapagos nv - filgotinib maleate - artritas, reumatas - imunosupresantai - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

Cardalis Euroopa Liit - leedu - EMA (European Medicines Agency)

cardalis

ceva santé animale - benazepril hydrochloride, spironolactone - Širdies ir kraujagysliŲ sistema - Šunys - gydymo stazinis širdies nepakankamumas, sukeltas lėtinių degeneracinių vožtuvų ligos šunims (su diuretikas paramos jei reikia).

Coxevac Euroopa Liit - leedu - EMA (European Medicines Agency)

coxevac

ceva santé animale - inaktyvinta vakcina "coxiella burnetii", devynių mylių kamienai - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.